Building the future of post-acute care
Post-acute care teams are buried in paperwork and pressured to respond fast. Responding first wins admissions, but often at the cost of fit, margins, and outcomes. ExaCare AI is building breakthrough AI agents that remove administrative burden, return time to care, and help every post-acute facility supercharge its workforce. Backed by world-class investors and trusted by 1,500+ facilities, we’re just getting started.
Our Story
Post-acute care coordination is broken. Admissions screening, insurance checks, authorizations, and reimbursement are slow, manual, and error-prone. The result: missed opportunities, financial leakage, burned-out staff, and misalignment with patient needs.
We founded ExaCare AI to fix this. Not with another point solution, but with a platform of AI agents purpose-built for the entire post-acute care workflow. Our AI agents work alongside admissions and operating teams to streamline decisions and documentation, reduce paperwork, improve consistency, and gain financial insights. ExaCare AI handles the busywork so teams can focus on what they do best: delivering excellent patient care.
ExaCare AI's Momentum
We’re building a future where post-acute providers aren’t competing on who can respond the fastest. Instead they’re competing on patient experience and outcomes.
We’re committed to delivering:
- Proprietary and highly refined AI models purpose-built for healthcare
- Continuous innovation
- Strong customer empathy and support
- Partnership beyond implementation
raised
facilities
referrals reviewed
Meet Our Team
We’re a trailblazing team of AI engineers, healthcare operators, and industry veterans united by a shared belief: technology should multiply human capability, not replace it. We combine a shared passion for high achievement with deep empathy for the challenges facing post-acute care. We believe the best talent should be building in healthcare.
AI engineers and operators with deep industry expertise
Backed by world-class investors
We raised our $30M Series A in 2025 from leading enterprise technology and healthcare investors who share our vision for leveraging AI to transform care.
Advised by industry-leading experts
